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ow Flow–Low Gradient
ortic Stenosis
he Pathologist Weighs In*
erard P. Aurigemma, MD, FACC,†
illiam H. Gaasch, MD, FACC‡
orcester and Burlington, Massachusetts
pproximately 2% of the population older than 65 years of
ge has aortic stenosis (AS) (1). Assuming this prevalence,
he number of individuals with AS older than 65 years of
ge in the U.S. in the year 2000 was approximately 700,000
2). In contemporary clinical practice, the initial diagnosis of
S is often made when a patient with a systolic ejection
urmur undergoes echocardiography. Given the ubiquity of
chocardiography and the increasing mean age of the
opulation, cardiologists will become increasingly occupied
ith issues related to the management of the patient with
S in the ensuing decades.
See page 1847
Doppler echocardiography is the method used in most
S cases to quantitate hemodynamic severity. Invasive
emodynamic measurements are also used to quantitate AS
everity, but in many centers, catheterization is reserved for
hose patients in whom coronary artery disease is suspected,
articularly when aortic valve replacement surgery (AVR) is
eing considered. In this issue of the Journal, Roberts and
o (3) introduce a third, albeit retrospective, method of
uantitating AS severity—weighing the excised aortic valve.
RINCIPAL FINDINGS
hese investigators report aortic valve weights in a series of
24 patients who underwent AVR with or without concom-
tant coronary artery bypass graft surgery. The individuals
ncluded in the study were culled from among 580 patients
ndergoing AVR for AS from 1998 to 2003. The 324
atients who comprised the final study population were
elected only if: 1) hemodynamic data were available, and 2)
he valve was available to be weighed by Dr. Roberts. This
ork extends previous observations by the same authors,
herein the weights of aortic valves were tabulated but no
emodynamic data were reported (4).
The principal findings of the paper are that: 1) aortic
alve weights were inversely correlated with the number of
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Division of Cardiology, Department of Medicine, University ofg
assachusetts Medical School, Worcester, Massachusetts; and the ‡Department of
ardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts.usps: trileaflet valves weighed the least, and the heaviest
alves were usually bicuspid; 2) there was a positive corre-
ation between the peak pressure gradient obtained at
atheterization and valve weight; and 3) the correlation
etween valve area—estimated by the Gorlin equation—
nd valve weight was not as close as that between valve
radient and valve weight.
OW FLOW–LOW GRADIENT AS
n the opinion of the authors, the major importance of their
bservations is that their data are not consistent with the
onventional wisdom concerning “low flow–low gradient”
S (5–7). This term is usually used to describe the condi-
ion in which AS coexists with severe left ventricular (LV)
ystolic dysfunction, usually related to coronary artery dis-
ase. A consensus definition of low flow–low gradient AS,
owever, is lacking. Many require a mean gradient30 mm
g and a valve area below 1 cm2 (6). Roberts and Ko (3) do
ot give mean gradient data, so it is difficult to compare
heir data with prior studies.
An inspection of Figures 2 and 3 in the Roberts and Ko
tudy (3) shows that low gradients are commonly seen in
atients undergoing AVR for AS: about one-fifth of the
atients had a peak transvalvular gradient below 30 mm Hg,
ven when the patients undergoing concomitant coronary
rtery bypass graft surgery were excluded. It is likely that
any more individuals in their study would have a mean
radient below this number. In such patients, especially
hose with very low ejection fraction, it may be difficult for
he clinician to interpret a small (e.g., 1 cm2) Gorlin
ormula-derived valve area. Is the calculated effective orifice
rea small because of true stenosis or because of deficient
pening-force generation by the ventricle, or are the data
nreliable because of the flow dependence of aortic valve
rea formulae?
A number of hemodynamic studies have shown that some
ndividuals experience an increase in valve area when flow is
ugmented with either exercise or dobutamine (5–9). Some
f these individuals probably do not have true severe AS
5–8), underscoring the flow dependence of current meth-
ds of assessing effective valve orifice area. Roberts and Ko
3) interpret their finding of a higher correlation coefficient
etween pressure gradient and valve weight than that
etween valve area and valve weight as evidence of the
nreliability of the Gorlin formula. They suggest that true
S is not present unless a significant transvalvular gradient
s present.
ALVE WEIGHT: THE COURT OF HIGHEST APPEAL?
ertainly these provocative observations provide a novel
nsight into the pathophysiology of AS. However, there are
ome reasons to be cautious in accepting these findings. We
ould offer no argument to the proposition that the valve
radient and valve weights are direct measurements, and are
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November 2, 2004:1856–8 Editorial Commentikely to be more accurate than a derived valve area. This
oes not necessarily invalidate the valve area calculation. A
umber of studies have confirmed a poor outcome in
ndividuals with AS and a low transvalvular gradient: the
perative mortality associated with low flow–low gradient
S has been in the range of 33% in several studies (5,
,10,11). Some of these studies have also reported operative
onfirmation of a severely stenotic aortic valve. Secondly, it
s difficult at this time to know whether the valve weight
epresents “the court of highest appeal” in the assessment of
S severity. We are inclined to trust the principal author on
his issue, and, given the rarity of rheumatic disease as a
ignificant cause for AS in the U.S., it seems reasonable to
ssume that a heavier valve means more calcification and
orse stenosis. At this time, however, little literature exists
n the weights of excised aortic valves, and no other study
as correlated in vivo hemodynamic data with aortic valve
eights. It is likely that the current study (3) will stimulate
urther validation work in this area.
There are also limitations related to the fact that this
tudy is retrospective. As the authors acknowledge, there
as a lack of a rigorous hemodynamic standard used for
easurements of gradients and valve areas, although it could
e argued that errors so encountered would not necessarily
e clustered in one anatomic/weight subtype. It is also
ossible, given the recent attention being paid the impor-
ance of prosthesis-patient mismatch (12), that indexation
f the valve area for body surface area might have improved
he correlation between valve area and valve weight.
Finally, the clinician’s rationale regarding the decision to
erform AVR cannot be assessed in a retrospective study.
igures 2 and 3 of their study (3) seem to show a slightly
igher frequency of coronary artery bypass graft surgery
mong the patients with a low transvalvular gradient. This
uggests the possibility that some of these individuals might
ave had symptomatic coronary artery disease (and related
V dysfunction) as the more compelling reason for surgery.
MPORTANCE OF THESE FINDINGS
hese limitations notwithstanding, this study represents an
mportant contribution to our understanding of AS. The
esults emphasize that the AS many of us learned about in
edical school is very different from the one we are
ncountering in contemporary practice. Increasingly this
newer” AS is degenerative (calcification of a trileaflet valve)
n contrast to inherently pathological (bicuspid, unicuspid,
nd other). This is underscored by the fact that 54% of the
atients in this study had a trileaflet aortic valve, an even
reater percentage than was observed in the 1980s (13). In
he current study, more than one-half the patients under-
ent coronary artery bypass graft surgery at the same time,
ith many, as we have seen, having a low transvalvular
radient documented at catheterization. Therefore, it is
ifficult to argue with the possibility, raised by the authors,
hat this current version of AS might be more affected byhe hemodynamic vagaries of the valve area equation or
ormula.
Secondly, if the importance of valve weights is confirmed
y other investigators, it is conceivable that dissemination of
oberts and Ko’s (3) results might alter practice patterns, as
linicians might be compelled to check on the valve weights
n patients in whom surgery was recommended. It is even
ossible that the frequency of heavy valves excised at surgery
ight be used as a parameter to judge the quality of a
ardiology/cardiothoracic surgery program.
One might argue that from the patient’s perspective, the
ost important criterion of the appropriateness of an AVR
s whether he or she feels better or lives longer following the
rocedure. The cardiologist can measure end points such as
mprovement in ejection fraction and LV mass regression,
oth of which occur after AVR (14). Some patients with
ow flow–low gradient AS also experience a dramatic
ncrease in ejection fraction after AVR, even in the presence
f significant coronary disease (15,16). If future work is
timulated by the findings of Roberts and Ko (3), as we
uspect will happen, perhaps the relationship between valve
eight and regression of hypertrophy and improvement in
jection fraction will be clarified. Quantitation of symptom
mprovement, as it relates to valve characteristics, will help
s to improve on patient selection for AVR.
eprint requests and correspondence: Dr. Gerard P. Au-
igemma, UMassMemorial Medical Center, Division of Cardiol-
gy, Room S3-860, 55 Lake Avenue North, Worcester, Massa-
husetts 01655-0002. E-mail: aurigemg@ummhc.org.
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